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Abstract
The enterochromaffin-like (ECL) cells play an important role in the regulation of gastric acid secretion. They respond to
gastrin by a prompt increase in histamine secretion, an effect which is mediated by the CCK-B/gastrin receptor acting
through the IP3/DAG pathway. In the rat, long-term treatment with acid secretion inhibitors induces hypergastrinaemia
which, in turn, results in ECL cell hypertrophy and hyperplasia. The aim of the present study was to evaluate various
functional parameters in acutely isolated rat ECL cells, following long-term hypergastrinaemia in vivo. Rats were treated
with vehicle or a supramaximal daily dose of omeprazole for more than 10 weeks to ensure ECL cell hyperplasia. ECL cells
were isolated from vehicle-treated animals and 24, 72 and 120 h after the last dose of omeprazole. The functional activity of
the acutely isolated ECL cells was determined by measuring gastrin-and forskolin-induced histamine secretion. Changes in
cytosolic free calcium upon gastrin stimulation were monitored by digital video imaging. ECL cells successively regained
their ability to respond to gastrin following long-term hypergastrinaemia, reaching close to vehicle-treated levels 120 h after
the last dose of omeprazole. In the rat, the response pattern of the ECL cells appears to normalise in parallel with the
normalisation of plasma gastrin levels. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The endocrine cells play a major role in the func-
tional regulation of the gastrointestinal tract. In the
mammalian stomach they constitute approximately
1^2% of the total number of cells in the gastric mu-
cosa [1]. The enterochroma⁄n-like (ECL) cells,
which play a central role in the regulation of gastric
acid secretion, are the predominant endocrine cell
population in the oxyntic mucosa. They constitute
approximately 65% of all fundic endocrine cells in
the rat [1,2] and about 35% in man [3]. The ECL
cells synthesise, store and secrete histamine which,
in turn, stimulates the parietal cells via the histamine
(H2)-receptor to secrete hydrochloric acid. The rela-
tionship between gastric acid secretion and gastrin
has been extensively studied. Gastrin, apart from
stimulating acid secretion, has a general trophic ef-
fect on the oxyntic mucosa. The ECL cells are the
most sensitive cells to the growth-stimulating e¡ect
of gastrin. Their acute response to gastrin is hista-
mine release and accelerated rate of synthesis of the
histamine-forming enzyme, histamine decarboxylase
(HDC). If high circulating gastrin levels are sustained
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for a few days, the ECL cells become hypertrophic
[4], and if the hypergastrinaemia is prolonged for
several weeks, an ECL cell hyperplasia develops.
The development of ECL cell hyperplasia probably
re£ects an accelerated rate of self replication under
the in£uence of gastrin [5,6].
Reduction of gastric acid secretion from the pari-
etal cells is known to increase circulating gastrin lev-
els. Therefore, treatment with antisecretory drugs
will induce hypergastrinaemia. This e¡ect is reversi-
ble when acid secretion is normalised; upon cessation
of treatment the gastrin level returns to control val-
ues [7]. Thus, inhibition of gastric acid secretion
raises the level of circulating gastrin, resulting in hy-
pergastrinaemia, which in turn results in an increase
in the ECL cell number. Over time, there is a linear
relationship between ECL cell density and plasma
gastrin concentration [8].
The response of the ECL cells to gastrin has been
extensively studied in the rat as well as in isolated
ECL cell preparations [9^13]. Gastrin stimulates his-
tamine secretion via the cholecystokinin B (CCKB)
receptor via a calcium-dependent pathway [14]. How-
ever, the studies on isolated cells were performed on
cells from untreated animals. We have modi¢ed the
isolation technique previously developed by Prinz et
al. [11] in order to allow isolation of the hypertrophic
ECL cells resulting from long-term hypergastrinae-
mia.
In this study, hypergastrinaemia was induced by
administration of a supramaximal dose of omepra-
zole (400 Wmol/kg per day) ^ which induces nearly
total inhibition of gastric acid secretion for 24 h ^ for
more than 10 weeks to ensure ECL cell hyperplasia/
hypertrophy. ECL cells were then isolated at various
times after the last dose of omeprazole, and the ef-
fects of gastrin on histamine secretion and on cyto-
solic free calcium, [Ca2]i, were investigated.
2. Materials and methods
2.1. Treatment of animals
Female Sprague^Dawley rats (MÖllegaard’s Breed-
ing Centre, Skensved, Denmark), weighing approxi-
mately 200^225 g at the start of the study, were used.
The animals were kept in groups of two or three in
Macrolon cages with free access to standard rat food
pellets and tap water. One group of animals received
omeprazole, 400 Wmol/kg, suspended in 0.25% (w/v)
bu¡ered methyl-cellulose, orally once daily at 10 a.m.
The control animals were given the vehicle only. The
rats were treated for at least 10 weeks and then killed
by carbon dioxide asphyxiation at various times after
the last dose. All animal experiments had been ap-
proved by the local animal welfare committee.
2.2. Isolation and enrichment of rat ECL cells
2.2.1. Solutions
All solutions were freshly prepared daily. Medium
A contained (in mM): 70 NaCl, 5 KCl, 1 Na2HPO4,
0.5 NaH2PO4, 20 NaHCO3, 10 EDTA, 50 Hepes, 11
glucose, and 5 mg/ml bovine serum albumin (BSA),
pH 7.8. Medium B contained (in mM): 70 NaCl,
5 KCl, 1 Na2HPO4, 0.5 NaH2PO4, 20 NaHCO3,
100 CaCl2, 15 MgCl2, 50 Hepes, 11 glucose, and
5 mg/ml BSA, pH 7.4. Medium C contained (in
mM): 140 NaCl, 12 MgSO4, 10 CaCl2, 15 Hepes,
11 glucose, 0.5 dithiothreitol, and 1 mg/ml BSA,
pH 7.4. Nycodenz stock solution contained Nyco-
denz from the bottle supplemented with 1.2 mM
MgCl2, 15 mM Hepes, and 10 mg/ml BSA, pH 7.4.
Histamine release medium contained Dulbecco’s
modi¢ed Eagle’s medium F-12 Ham supplemented
with 3 mg/ml BSA, 2% foetal calf serum, 0.5 mM
CaCl2, 1% ITS, 50 IU/ml penicillin, and 50 Wg/ml
streptomycin, pH 7.4.
2.2.2. Cell isolation
The isolation technique used was based on the
method previously developed by Prinz et al. [11].
Some modi¢cations to the isolation procedure had
to be made to allow isolation of hypertrophic ECL
cells. Brie£y, two (omeprazole-treated) or four (ve-
hicle-treated) non-fasting rats were used in each
preparation. The stomachs were rapidly excised and
placed in physiological saline. After ligation of the
oesophageal^gastric junction, the stomachs were
everted, ligations were thereafter performed, and
the fundic sacs were ¢lled with 3^5 ml of Pronase
(0.80 mg/ml, in medium A). The gastric sacs were
placed in a 250-ml E-£ask containing 150 ml of oxy-
genated medium A and incubated for 20 min. Unless
otherwise indicated, all incubations were performed
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at 37‡C under an oxygenated atmosphere. The me-
dium was then discarded and 150 ml of medium B
was added for 10 min. The sacs were once again
placed in 150 ml of medium A and incubated for
20 min. This medium was then replaced with 150 ml
of medium B and the stomachs were incubated for
10 min with gentle magnetic stirring. The sacs were
then transferred to 150 ml medium A for 20 min.
The medium was then replaced with 100 ml medium
B and stirred for 15 min. The medium was then
replaced with 75 ml fresh medium B and stirred for
another 20 min. Thereafter, the medium was ¢ltered
through a 75 Wm nylon mesh. After centrifugation,
this fraction of gastric mucosal cells (referred to as
M3) was resuspended in 10 ml of medium C contain-
ing 10 mg/ml BSA. The cell yield and viability were
assessed, using Trypan blue exclusion, after which
the cell concentration was adjusted to 15^16U106
cells/ml by adding medium C containing 10 mg/ml
BSA. The M3 cell fraction was left to rest at room
temperature for 60 min before further treatment.
2.2.3. ECL cell enrichment
The M3 suspension was subjected to counter£ow
elutriation using a JE-6 elutriator rotor with the
standard elutriation chamber (Beckman Instruments,
Palo Alto, CA, USA) run in a J-21C centrifuge
(Beckman). A Master£ex pump equipped with an
Easy Load pump head (Models 7550-92 and 7518-
00, respectively, Cole^Parmer Instrument Co., Bar-
rington, IL, USA) was used to regulate the £ow rate
of the bu¡er. Medium C was pumped through the
system, and care was taken to remove all bubbles.
About 1.0U108 cells were injected into the system, at
a £ow rate of 10 ml/min in each round. Two di¡erent
elutriation protocols had to be used due to the ECL
cell hypertrophy in omeprazole-treated animals (Ta-
ble 1). The cells in the F2 fractions were collected by
centrifugation, 150Ug for 5 min, and resuspended in
histamine release medium. The cells were incubated
at 25‡C for 3 h before further treatment.
In order to obtain maximal enrichment of both
normal (vehicle-treated) and hypertrophic (omepra-
zole-treated) ECL cells, two di¡erent density gradient
systems had to be used.
In the experiments with vehicle-treated animals,
the partly enriched ECL cell fraction (F2) was over-
laid above two di¡erent layers of Nycodenz stock
solution mixed with medium C containing 10 mg/
ml BSA and 1.2 mM MgCl2 (1:1 (1.058 g/ml) and
1:2 (1.046 g/ml) mix) and centrifuged at 200Ug for
8 min. Finally, enriched ECL cells were collected at
the top interface. The collected fraction was washed
with histamine release medium.
For the omeprazole-treated animals, a linear den-
sity gradient ranging between 1.044 g/ml and 1.078 g/
ml (9 ml of each) had to be used. The gradient was
prepared using a Bio-Rad gradient former, model
385. The partly enriched ECL cell fraction (F2)
was laid over the linear density gradient and centri-
fuged at 200Ug for 8 min. The ¢nally enriched ECL
cells were then collected as a 5 ml-fraction, 3 ml from
the top. The collected fraction was then washed with
histamine release medium.
2.3. Immunocytochemistry
ECL cell density was determined by means of im-
munocytochemical staining. Staining was performed
using a polyclonal primary antibody raised in rabbit
against HDC. Alkaline phosphatase-conjugated, goat
anti-rabbit IgG was used as the secondary antibody.
Cell suspensions were left to dry on poly-L-lysine-
coated glass slides at room temperature overnight.
Cells were then pre¢xed in ice-cold acetone and
thereafter ¢xed in 1% formaldehyde and 0.25% glu-
taraldehyde. Cells were incubated with the primary
antibody (dilution 1:400), diluted with phosphate-
bu¡ered saline containing 2% (w/v) BSA and 0.25%
(v/v) Triton, for 2 h and then washed. The secondary
antibody was added for 2 h, and a commercially
available substrate-kit (DAKO New Fuchsin) was
used to visualise speci¢c primary antibody binding
in cells. Non-speci¢c binding was blocked by prein-
cubation with 25% goat serum. At least 200 cells per
preparation were counted in di¡erent visual ¢elds at
a magni¢cation of 400U. Data are expressed as pos-
itive cells per total number of cells.
2.4. Histamine release experiments
The histamine content and the histamine released
were determined in the ¢nally enriched ECL fraction
as follows. Cells were incubated in Eppendorf vials
(5U5000 cells/vial, total volume 200 Wl) at 37‡C
under an oxygenated atmosphere under the indicated
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experimental conditions. DMSO was used as a ve-
hicle for gastrin and forskolin, at a ¢nal concentra-
tion of less than 0.1%. At these concentrations,
DMSO did not alter histamine release. The incuba-
tion was stopped after 60 min by centrifugation
(1500Ug, 3 min) and the supernatant was removed.
The histamine content was determined at time zero,
after removal of the supernatant for measurement of
initial extracellular histamine, the cell suspension was
homogenised by sonication, and the histamine con-
tent was determined. All samples were diluted and
stored at 320‡C until histamine analysis. The hista-
mine concentration was measured with a commer-
cially available radioimmunoassay kit.
2.5. Video imaging of intracellular calcium
The ¢nally enriched ECL fraction was resuspended
in histamine release medium and allowed to rest for
3 h at room temperature. The cells were then placed
on poly-L-lysine-coated glass cover slips (q 22 mm)
in an open chamber for 15 min at 37‡C, to ensure
attachment, before addition of medium C containing
2 WM Fura-2 AM. After 30 min incubation at 37‡C,
the chamber was placed on the stage of an inverted
microscope (Nikon Diaphot 300, Tokyo, Japan)
equipped for epi£uorescence. The chamber was per-
fused with medium C at 37‡C, at a £ow rate of 1 ml/
min, for 5^10 min before stimulation. The stimulant
was then added for 3 min and replaced with medium
C until the cells had returned to their prestimulated
state. Then a second gastrin concentration (10 times
higher than the ¢rst) was added for 3 min, after
which it was replaced with medium C. Cells were
allowed to return to prestimulated values, after
which ionomycin (10 WM) followed by EGTA
(10 mM) was added in order to obtain maximum
and minimum £uorescence levels. Fura-2 £uores-
cence, as well as background £uorescence, was im-
aged using a Nikon UV-Fluor objective (40U, N.A.
1.3). Fluorescent emission was monitored by an in-
tensi¢ed video camera (Dage-MTI CCD-72) and ex-
pressed as the ratio (R340/R380) of the £uorescence
intensity of selected cells, under the control of Ratio-
Tool software (Inovision Corporation, Raleigh, NC,
USA). [Ca2]i was calculated according to Grynkie-
wicz et al. [15], assuming a dissociation constant of
224 nM. Cells were excluded if they did not remain
visible throughout the experiment.
2.6. Presentation of the data and statistical analysis
The data presented correspond to the mean þ
standard error of the mean (S.E.M.). Data corre-
sponding to video imaging of intracellular calcium
were expressed as mean peak [Ca2]i þ S.E.M. E¡ec-
tive concentrations 50% (EC50) were calculated using
linear regression analysis. Di¡erences between ome-
prazole-treated groups and vehicle-treated groups
were compared with the Mann^Whitney U-test.
P6 0.05 was considered to be signi¢cant.
2.7. Chemicals
All chemicals were of analytical grade and ob-
tained from the indicated sources: bovine serum al-
bumin, Fraction V (BSA), carbamylcholine (carba-
chol), dithiothreitol, Dulbecco’s modi¢ed Eagle’s
medium F12 Ham, ethylenediamine tetraacetic acid
(EDTA), ethylene glycol-bis(L-aminoethyl ether)-
Table 1
Elutriation protocols for the enrichment of ECL cells from vehicle-treated and omeprazole-treated animals
Vehicle-treated animals Omeprazole-treated animals
Rotor speed
(rpm)
Flow rate
(mg/ml)
Volume collected
(ml)
Rotor speed
(rpm)
Flow rate
(mg/ml)
Volume collected
(ml)
F0 2000 10 50 2000 15 50
F1 2000 15 50 2000 23 100
F2a 2000 21 100 2000 27 100
F3 2000 50 100 2000 50 100
Elutriation at 25‡C.
aThe ECL cell-rich fraction.
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N,N,NP,NP-tetraacetic acid (EGTA), and N-[2-hy-
droxy ethyl]piperazine-NP-[2-ethanesulfonic acid]
(Hepes) were from Sigma Chemical Co. (St. Louis,
MO, USA). Cell-Tak and ITS-culture supplement
(6.25 Wg/ml insulin, 6.25 Wg/ml transferrin, 6.25 ng/ml
selenous acid, 1.25 mg/ml BSA, 5.35 Wg/ml linoleic
acid) were from Collaborative Biomedical, Bedford,
MA, USA. Pronase E was from Boehringer Mann-
heim, Mannheim, Germany. Rat gastrin-17 was
from Peninsula Laboratories, Belmont, CA, USA.
7L-Acetoxy-8,13-epoxy-1K,6L,9K-trihydroxy-labd-14-
ene-11-one (forskolin) was from Calbiochem, La
Jolla, CA, USA. Methocel was from Dow Corning
Corp., Midland, MI, USA. Nycodenz (NycoPrep
1.150) was from Nycomed, Oslo, Norway. Normal
goat serum and DAKO New Fuchsin Substrate Sys-
tem were from DAKO, Glostrup, Denmark. Alkaline
phosphatase goat-anti-rabbit IgG was from Vector
Laboratories, Burlingame, CA, USA. Omeprazole
was from AstraZeneca, Mo«lndal, Sweden. The hista-
mine radioimmunoassay kit was from Immunotech,
Marseilles, France. Foetal calf serum, penicillin/
streptomycin solution, and Trypan blue were from
Life Technologies, Paisley, UK. The polyclonal rab-
bit-anti-HDC antibody was a generous gift from Dr.
Lo Persson, Department of Molecular and Cellular
Physiology, Lund University, Sweden. All other
chemicals were of the highest grade commercially
available.
3. Results
The ECL cell density was about 1^2% in the initial
cell suspension. After elutriation, regardless of elu-
triation protocol, the ECL density increased up to
about 20^30%. Two di¡erent density gradients were
used, one step-gradient for cells from vehicle-treated
animals and another linear one for the cells from
omeprazole-treated rats. The numbers of HDC-pos-
itive cells in the ¢nally enriched fractions were sim-
ilar, regardless of the isolation procedure employed
(Table 2). The average ECL cell density in the ¢nally
enriched cell fraction was 66 þ 2%. (Thus, the total
enrichment with respect to the gastric mucosa was
about 70-fold.) The histamine content was measured
just before the start of the histamine release experi-
ment. The histamine content ranged from 95^127
nmol per million ECL cells (Table 3). The histamine
content appears to be somewhat higher following
omeprazole treatment; this increase was, however,
not signi¢cant. Forskolin, a direct activator of ad-
enylate cyclase, was able to trigger histamine secre-
tion in cells isolated from vehicle-treated animals.
Table 3
Histamine content and forskolin (10 WM)-stimulated histamine secretion from ECL cells isolated from vehicle-treated animals and
from omeprazole-treated animals 24, 72, and 120 h after the last dose of omeprazole
Histamine content (nmol/106 ECL cells) Histamine secretion (nmol/106 ECL cells)
Vehicle-treated 95 þ 8 11.3 þ 2.9
Omeprazole 24 h 121 þ 16 2.7 þ 0.4*
Omeprazole 72 h 127 þ 12 8.9 þ 2.4
Omeprazole 120 h 111 þ 26 6.3 þ 1.1
Values are mean þ S.E.M. of ¢ve independent preparations.
*P6 0.05 as compared to vehicle-treated cells (Mann^Whitney U-test).
Table 2
ECL cell density in the ¢nally enriched fraction by means of histidine decarboxylase immunocytochemistry
Vehicle-treated animals (% ECL cells) Omeprazole-treated animals (% ECL cells)
Vehicle-treated 69.3 þ 2.4 n.a.
Omeprazole 24 h n.a. 66.2 þ 4.6
Omeprazole 72 h n.a. 62.8 þ 3.0
Omeprazole 120 h n.a. 67.2 þ 3.5
Values are mean þ S.E.M. of ¢ve independent preparations. n.a., not available.
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Thus, increases in cyclic AMP alone were able to
trigger histamine secretion. In cells isolated from
omeprazole-treated rats, 24 h after the last dose,
there was a signi¢cant decrease in forskolin-induced
histamine secretion. The response to forskolin in cells
isolated 72 and 120 h after the last dose of omepra-
zole was, however, not signi¢cantly di¡erent from
that in controls. Carbachol failed to stimulate hista-
mine secretion from ECL cells isolated from vehicle-
treated animals (data not shown).
3.1. E¡ects of gastrin on histamine secretion
Rat gastrin-17 stimulated histamine secretion in a
concentration-dependent manner. In all experiments
with cells isolated from vehicle-treated animals, the
maximal response was obtained at a concentration of
1038 M. Fig. 1 shows the concentration-dependent
histamine secretion after 1 h of incubation under
basal conditions and after addition of 10311^1037
M gastrin. The EC50 for gastrin was calculated to
be 0.2 nM in cells isolated from vehicle-treated ani-
mals. The same experiments with hypertrophic ECL
cells were repeated at three di¡erent time points, 24,
72 and 120 h, after stopping the omeprazole admin-
istration. Twenty-four hours after the last dose of
omeprazole, there was no functional response in
terms of increased histamine secretion above basal
levels. At the other time points, the ECL cells pro-
gressively regained their ability to respond to gastrin
stimulation, reaching close to control levels 120 h
after last dose. EC50 values 72 and 120 h after the
last dose of omeprazole were 0.4 nM and 1 nM,
respectively.
3.2. Gastrin e¡ects on cytosolic free Ca2+ in single
ECL cells
Changes in cytosolic free calcium upon gastrin
stimulation (10311^1037 M) were monitored in single
acutely isolated ECL cells using the £uorescent dye
Fura-2 and digital video imaging. ECL cells isolated
from vehicle-treated animals responded to a gastrin
challenge with a prompt increase in cytosolic free
calcium, whereas the cells isolated 24 h after ending
the omeprazole treatment showed a weaker response.
Fig. 2. ECL cells were isolated from vehicle-treated animals
and from animals 24 h after stopping omeprazole administra-
tion. Changes in intracellular calcium, [Ca2]i, in single acutely
isolated ECL cells were measured using Fura-2 and digital vid-
eo imaging. Basal [Ca2]i were 86 þ 4 and 50 þ 4 nM in cells
from vehicle-treated and omeprazole-treated animals, respec-
tively. Data are expressed as peak mean [Ca2]i þ S.E.M. from
basal levels following addition of gastrin from 6^46 individual
cells from 12 di¡erent preparations. EC50 values were calculated
using the response obtained with 0.1 WM gastrin as the maxi-
mum for vehicle-treated and omeprazole-treated, respectively.
*P6 0.05 as compared to cells from vehicle-treated animals
(Mann^Whitney U-test).
Fig. 1. Histamine secretion from isolated ECL cells in response
to gastrin. Cells were isolated from vehicle-treated animals and
24, 72 and 120 h after the last dose of omeprazole. Following
1 h of incubation with gastrin, at the indicated concentrations,
the supernatant was harvested and assayed for histamine.
Mean þ S.E.M. of ¢ve independent preparations. *P6 0.05 as
compared to vehicle-treated cells (Mann^Whitney U-test).
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At the higher gastrin concentrations, however, the
increments in [Ca2]i in these cells were similar to
those observed in cells isolated from vehicle-treated
animals (Fig. 2). Yet the cells isolated from the ome-
prazole-treated animals 24 h after last dose of ome-
prazole did not secrete histamine in response to gas-
trin (Fig. 1). The estimated EC50 values for the e¡ect
of gastrin on [Ca2]i were 3.7 nM in cells from ve-
hicle-treated animals and 4.2 nM in cells isolated
24 h after ending the treatment with omeprazole.
4. Discussion
Gastrin is a potent stimulant of gastric acid secre-
tion. The ECL cells are known to be under both
functional and trophic control of gastrin. Their
role, and that of histamine, in the regulation of gas-
tric acid secretion has been the focus of numerous
studies. In the present study, daily administration of
a supra-maximal dose of omeprazole (400 Wmol/kg
per day) was used to induce hypergastrinaemia (a
consequence of the profound inhibition of gastric
acid secretion). The hypergastrinaemia was sustained
for more than 10 weeks to ensure both ECL cell
hypertrophy and hyperplasia. Thereafter, the readi-
ness of the ECL cells to secrete histamine in response
to a gastrin challenge was determined. The CCKB
receptor function was assessed by monitoring gas-
trin-induced changes in cytosolic free calcium.
The modi¢ed isolation procedure enabled us to
harvest both normal and hypertrophic ECL cells
with similar ratios of enrichment. ECL cells isolated
from vehicle-treated animals secreted histamine in
response to gastrin in a concentration-dependent
manner. This response was nearly identical to that
previously reported [9,11]. The vehicle-treated cells
also responded with a prompt increase in cytosolic
free calcium. This is also in agreement with previous
observations [11,16,17]. In ECL cells isolated 24 h
after withdrawal of omeprazole, gastrin induced a
concentration-dependent increase in the cytosolic
free calcium level. The response was somewhat lower
than in cells isolated from vehicle-treated animals but
reached levels that induced near maximal secretion of
histamine in control cells. The ability of the ECL
cells to secrete histamine in response to gastrin grad-
ually returned, reaching close to vehicle-treated levels
120 h after discontinuation of omeprazole treatment.
Increases in cytosolic free calcium are both necessary
and su⁄cient for the initiation of secretion [18]. It
seems clear that additional signals, such as the acti-
vation of protein kinase C [19] or one or more G
proteins, are often required for the initiation of
non-excitable cells [20].
The ECL cells act as intermediate regulatory cells,
secreting histamine in response to food (gastrin) and
perhaps also to neural stimulation. The e¡ect of gas-
trin is mediated though the CCKB receptor. The
CCK receptors belong to the superfamily of G-pro-
tein-coupled receptors, many of which undergo inter-
nalisation within minutes after agonist exposure [21].
Both CCKA- and CCKB-receptors have been shown
to undergo ligand-induced internalisation in pancre-
atic acini [22] or transfected NIH 3T3 [23] cells, re-
spectively. During sustained hypergastrinaemia the
ECL cells might undergo a process of adaptation
resulting in down-regulation of gastrin receptors in
response to abnormally high gastrin levels. This
could explain the responses observed following
long-term treatment. In terms of the calcium re-
sponse 24 h after withdrawal of omeprazole com-
pared to that in cells from vehicle-treated animals,
the EC50 value remained unchanged (W4 nM). The
una¡ected EC50 value supports a decrease in receptor
number, perhaps through internalisation or receptor
recycling during agonist pressure, rather than recep-
tor desensitisation.
The cytoplasm of the ECL cells contains charac-
teristic granules and vesicles of varying size: secre-
tory vesicles, granules, microvesicles, and vacuoles.
Histamine is produced in the cytoplasm, then accu-
mulated and stored in the secretory vesicles until
release [24]. Long-term hypergastrinaemia is known
to increase not only the ECL cell density but also the
ECL cell size. The hypertrophy is maximal after
2 weeks of sustained hypergastrinaemia [4]. Ultra-
structural changes occur and, perhaps most impor-
tantly, the number of secretory vesicles decreases.
Furthermore, there is also the introduction of large
vacuoles thought to be the result of fusion between a
number of secretory vesicles [25]. These vacuoles may
play a role in the degradation of overproduced secre-
tory products (including histamine). Their ability,
compared to the secretory vesicles, to respond to a
gastrin stimulus is thought to be impaired. The fact
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that forskolin, a direct activator of adenylate cyclase,
failed to release histamine supports this view. Upon
withdrawal of omeprazole, the serum gastrin concen-
trations promptly returns to the pretreatment level
[26]. The ECL cell function should therefore return
to normal upon withdrawal of omeprazole, parallel
to the gastrin concentration. The mechanisms behind
the reversibility of the gastrin-evoked changes are far
from clear. The hypertrophy of the ECL cells is com-
pletely reversed within 40 days. Within 5 days of
ending omeprazole administration it was found that
the vacuoles had completely vanished and that a
marked increase in the number of secretory vesicles
has occurred [25,27]. Five days appear to be su⁄-
cient for the ECL cells to normalise cell functions,
to form new functional secretory vesicles, and/or reg-
ulate receptor function before being able to respond
to gastrin.
In summary, a method has been optimised which
enables enrichment of ECL cells from both normal
and hypertrophic gastric mucosa. The histamine re-
lease experiments showed that ECL cells respond to
gastrin challenge in a concentration-dependent man-
ner (EC50 = 0.2 nM). Twenty-four hours after the last
dose of omeprazole, there was no signi¢cant increase
in histamine secretion following a gastrin challenge.
The ECL cells successively regained their ability to
respond to gastrin, reaching vehicle-treated levels
after 5 days. The weak but signi¢cant increments in
[Ca2]i in response to gastrin, observed 24 h after
stopping the omeprazole treatment, indicate that
the ECL cells are capable of responding to gastrin
by increasing [Ca2]i. Why that does not result in a
signi¢cant increase in histamine secretion could be
due to a combination of receptor internalisation
and/or post-receptor modulation and an impaired
vesicle function.
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